Daiwa Securities Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28M Buy
270,906
+54,075
+25% +$4.83M 0.05% 197
2026
Q1
$15.6M Buy
216,831
+11,862
+6% +$914K 0.04% 237
2025
Q4
$16.3M Buy
204,969
+6,733
+3% +$531K 0.05% 214
2025
Q3
$14.9M Sell
198,236
-17,916
-8% -$1.23M 0.05% 215
2025
Q2
$14.9M Buy
216,152
+37,509
+21% +$2.46M 0.06% 200
2025
Q1
$12.1M Buy
178,643
+13,329
+8% +$798K 0.05% 213
2024
Q4
$7.42M Buy
165,314
+11,955
+8% +$671K 0.03% 297
2024
Q3
$9.64M Buy
153,359
+16,549
+12% +$965K 0.04% 232
2024
Q2
$8.08M Buy
136,810
+10,560
+8% +$661K 0.04% 237
2024
Q1
$10.1M Buy
126,250
+11,149
+10% +$852K 0.06% 195
2023
Q4
$9.09M Buy
115,101
+6,899
+6% +$491K 0.06% 189
2023
Q3
$7.55M Buy
108,202
+5,818
+6% +$412K 0.05% 196
2023
Q2
$7.08M Sell
102,384
-4,392
-4% -$313K 0.05% 213
2023
Q1
$7.93M Buy
106,776
+4,386
+4% +$368K 0.06% 188
2022
Q4
$9.54M Buy
102,390
+5,042
+5% +$487K 0.07% 166
2022
Q3
$9.28M Buy
97,348
+7,257
+8% +$718K 0.08% 149
2022
Q2
$8.35M Sell
90,091
-1,367
-1% -$133K 0.06% 167
2022
Q1
$9.26M Sell
91,458
-7,768
-8% -$816K 0.06% 177
2021
Q4
$10.2M Sell
99,226
-1,221
-1% -$113K 0.06% 170
2021
Q3
$8.52M Buy
100,447
+17,825
+22% +$1.49M 0.06% 175
2021
Q2
$6.89M Buy
82,622
+9,884
+14% +$809K 0.05% 181
2021
Q1
$5.47M Buy
72,738
+2,709
+4% +$197K 0.04% 196
2020
Q4
$4.78M Buy
70,029
+1,923
+3% +$125K 0.04% 218
2020
Q3
$3.98M Buy
68,106
+4,196
+7% +$261K 0.04% 209
2020
Q2
$3.79M Hold
63,910
0.08% 131
2020
Q1
$3.79M Sell
63,910
-4,289
-6% -$286K 0.04% 200
2019
Q4
$5.07M Buy
68,199
+889
+1% +$62.4K 0.04% 193
2019
Q3
$4.25M Buy
67,310
+1,202
+2% +$71.2K 0.04% 211
2019
Q2
$3.6M Sell
66,108
-1,100
-2% -$59.2K 0.03% 228
2019
Q1
$3.62M Sell
67,208
-24,969
-27% -$1.54M 0.03% 229
2018
Q4
$6.04M Buy
92,177
+9,217
+11% +$688K 0.06% 152
2018
Q3
$6.53M Buy
82,960
+2,568
+3% +$184K 0.05% 176
2018
Q2
$5.17M Buy
80,392
+15,817
+24% +$1.04M 0.04% 226
2018
Q1
$4.02M Buy
64,575
+27,077
+72% +$1.94M 0.03% 262
2017
Q4
$2.72M Sell
37,498
-5,541
-13% -$403K 0.02% 331
2017
Q3
$3.5M Buy
43,039
+6,326
+17% +$500K 0.02% 260
2017
Q2
$2.95M Sell
36,713
-72
-0.2% -$5.68K 0.02% 265
2017
Q1
$2.89M Buy
36,785
+937
+3% +$74.8K 0.02% 278
2016
Q4
$2.83M Sell
35,848
-114,551
-76% -$9.27M 0.02% 231
2016
Q3
$13.4M Buy
150,399
+4,750
+3% +$448K 0.08% 85
2016
Q2
$13.9M Buy
145,649
+10,950
+8% +$1.09M 0.08% 79
2016
Q1
$14M Buy
134,699
+22,500
+20% +$2.19M 0.09% 83
2015
Q4
$11M Sell
112,199
-43,700
-28% -$4.28M 0.07% 99
2015
Q3
$15M Sell
155,899
-7,650
-5% -$804K 0.11% 83
2015
Q2
$17.2M Sell
163,549
-3,000
-2% -$307K 0.12% 78
2015
Q1
$17.2M Buy
166,549
+108,100
+185% +$10.9M 0.12% 70
2014
Q4
$5.63M Sell
58,449
-85,700
-59% -$7.55M 0.04% 141
2014
Q3
$11.5M Sell
144,149
-3,900
-3% -$307K 0.09% 86
2014
Q2
$11.2M Buy
148,049
+78,400
+113% +$5.93M 0.08% 89
2014
Q1
$5.21M Buy
69,649
+28,300
+68% +$2M 0.04% 145
2013
Q4
$2.96M Sell
41,349
-3,300
-7% -$212K 0.03% 170
2013
Q3
$2.53M Sell
44,649
-1,325
-3% -$79K 0.02% 191
2013
Q2
$2.63M Buy
+45,974
New +$2.66M 0.02% 203

Other funds holding CVS

Daiwa Securities Group's CVS Position: Q2 2026 in Review

Daiwa Securities Group increased its CVS Health (CVS) stake by 25% in Q2 2026, buying an estimated $4.83M and bringing the position to 270,906 shares worth $28M. The position accounts for 0.05% of the portfolio, ranked #197.

Daiwa Securities Group first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Daiwa Securities Group held 270,906 shares of CVS Health worth $28M as of Q2 2026.
  • Daiwa Securities Group bought 54,075 CVS Health shares in Q2 2026, an estimated $4.83M.
  • CVS Health made up 0.05% of Daiwa Securities Group's portfolio in Q2 2026, its #197 holding.
  • Daiwa Securities Group first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.